Glutathione-Depleting Pro-Oxidant as a Selective Anticancer Therapeutic Agent

[Image: see text] A main challenge in the development of anticancer drugs that eradicate cancer cells specifically with minimal toxicity to normal cells is to identify the cancer-specific properties. Cancer cells sustain a higher level of reactive oxygen species, owing to metabolic and signaling abe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Donghyuck, Jung, Eunkyeong, Noh, Joungyoun, Hyun, Hyejin, Seon, Semee, Hong, Seri, Kim, Dongin, Lee, Dongwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648603/
https://www.ncbi.nlm.nih.gov/pubmed/31460099
http://dx.doi.org/10.1021/acsomega.9b00140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648603/
https://www.ncbi.nlm.nih.gov/pubmed/31460099
http://dx.doi.org/10.1021/acsomega.9b00140

Ejemplares similares